Close Search

Honors & Awards


  • $50,000.00
    Jonathan Lifshitz
    Arizona Statewide Alzheimer's Research
    COM Phx Child Health
  • $503,260.68
    Jarrod Mosier
    Study to Assess the Efficacy and Safety of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo in Patients with COVID-19
    Dept of Emergency Medicine
    Clinical Trial
  • $11,884,298.00
    Stephen Black
    Metabolic Reprogramming and Pulmonary Vascular Disease in Congenital Heart Disease



Expert Insights: Why Should You Get a Flu Shot this Year?

In The Media

  • Continuing coverage: Investigators have determined that treating patients with an advanced form of age-related macular degeneration with levodopa, a safe and readily available drug commonly used to treat Parkinson's disease, stabilized and improved their vision. It reduced the number of treatments necessary to maintain vision, and as such, will potentially reduce the burden of treating the disease, financially and otherwise. Dr. Robert W. Snyder, head of the Department of Ophthalmology at the University of the Arizona, is the study's lead investigator.

  • The Week - September 16

    Continuing coverage: Colleges and universities across the U.S. are looking into using wastewater-based epidemiology to track the spread of COVID-19. Wastewater samples from the Likins dorm on the University of Arizona campus came back positive for COVID-19, according to University of Arizona President Robert C. Robbins. Ian Pepper, director of the WEST Center and a BIO5 Institute member, is leading a study that uses municipal wastewater to monitor the incidence of the virus in communities across the United States. 

  • The Associated Press - September 16

    Continuing coverage: Molecular clock analysis showed no widespread community distribution of the highly contagious coronavirus disease in Arizona until mid-February.